Literature DB >> 7819336

Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example.

M S Medeiros1, A J Turner.   

Abstract

Post-secretory metabolism is an important event in the overall homeostasis of regulatory peptides and the enzymes involved in these processes may be suitable targets for pharmacological intervention. Some examples are reviewed here. Peptide YY and neuropeptide Y, both members of the pancreatic polypeptide family, can be processed by dipeptidyl peptidase IV to their (3-36) fragments by removal of the N-terminal Tyr-Pro dipeptide, which generates a metabolite of different receptor selectivity. Aminopeptidase P and endopeptidase-24.11 also metabolize these peptides and the relative levels of these three cell-surface enzymes may regulate their interconversion between receptor-selective forms and inactive metabolites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819336     DOI: 10.1016/0300-9084(94)90159-7

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Proteomic analysis reveals APC-dependent post-translational modifications and identifies a novel regulator of β-catenin.

Authors:  Malachi A Blundon; Danielle R Schlesinger; Amritha Parthasarathy; Samantha L Smith; Hannah M Kolev; David A Vinson; Ezgi Kunttas-Tatli; Brooke M McCartney; Jonathan S Minden
Journal:  Development       Date:  2016-06-10       Impact factor: 6.868

2.  Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat.

Authors:  Nicholas G Moss; Dorothy A Riguera; Robert C Fellner; Christopher Cazzolla; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

3.  Link peptide cartilage growth factor is degraded by membrane proteinases.

Authors:  M F Dean; P Sansom
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

4.  Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.

Authors:  John B Rose; Leslie Crews; Edward Rockenstein; Anthony Adame; Michael Mante; Louis B Hersh; Fred H Gage; Brian Spencer; Rewati Potkar; Robert A Marr; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

5.  A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.

Authors:  U V Wesley; A P Albino; S Tiwari; A N Houghton
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

6.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.